Li P, Chen L, Liu J
Front Med (Lausanne). 2024; 11:1454776.
PMID: 39355840
PMC: 11443508.
DOI: 10.3389/fmed.2024.1454776.
Jiang Z, Wang X, Zhou Z, Peng L, Lin X, Luo X
BMC Plant Biol. 2024; 24(1):157.
PMID: 38424498
PMC: 10905880.
DOI: 10.1186/s12870-024-04828-9.
Ma S, Guo X, Han R, Meng Q, Zhang Y, Quan W
Front Pharmacol. 2024; 15:1355644.
PMID: 38384287
PMC: 10880095.
DOI: 10.3389/fphar.2024.1355644.
Ozcan G
Front Oncol. 2023; 13:1216438.
PMID: 37700842
PMC: 10493393.
DOI: 10.3389/fonc.2023.1216438.
Matherne M, Phillips E, Embrey S, Burke C, Machado H
Front Oncol. 2023; 13:1111522.
PMID: 36761942
PMC: 9905667.
DOI: 10.3389/fonc.2023.1111522.
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
LeBlanc F, Hasanali Z, Stuart A, Shimko S, Sharma K, Leshchenko V
Oncotarget. 2022; 13:986-1002.
PMID: 36093297
PMC: 9450988.
DOI: 10.18632/oncotarget.28258.
CDK4: a master regulator of the cell cycle and its role in cancer.
Baker S, Poulikakos P, Irie H, Parekh S, Reddy E
Genes Cancer. 2022; 13:21-45.
PMID: 36051751
PMC: 9426627.
DOI: 10.18632/genesandcancer.221.
Oxysterol derivatives Oxy186 and Oxy210 inhibit WNT signaling in non-small cell lung cancer.
Tang L, Spezia M, Chen T, Shin J, Wang F, Stappenbeck F
Cell Biosci. 2022; 12(1):119.
PMID: 35908024
PMC: 9338492.
DOI: 10.1186/s13578-022-00857-9.
Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis.
Muller H, Walter W, Hutter S, Nadarajah N, Meggendorfer M, Kern W
Cancer Gene Ther. 2022; 29(5):484-493.
PMID: 35145272
PMC: 9113931.
DOI: 10.1038/s41417-022-00428-7.
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics.
Franz A, Coscia F, Shen C, Charaoui L, Mann M, Sander C
J Ovarian Res. 2021; 14(1):140.
PMID: 34686201
PMC: 8539835.
DOI: 10.1186/s13048-021-00886-x.
Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.
Hang C, Gong C, Fang Y, Chen L, Zhu J
J Mol Histol. 2021; 52(2):187-196.
PMID: 33394290
DOI: 10.1007/s10735-020-09934-0.
Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.
Wang Y, Yella J, Ghandikota S, Cherukuri T, Ediga H, Madala S
Ther Adv Respir Dis. 2020; 14:1753466620971143.
PMID: 33167785
PMC: 7659024.
DOI: 10.1177/1753466620971143.
Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
Hong S, Cai W, Huang Z, Wang Y, Mi X, Huang Y
Oncol Rep. 2020; 44(4):1333-1342.
PMID: 32945504
PMC: 7448421.
DOI: 10.3892/or.2020.7728.
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action.
McFarland J, Paolella B, Warren A, Geiger-Schuller K, Shibue T, Rothberg M
Nat Commun. 2020; 11(1):4296.
PMID: 32855387
PMC: 7453022.
DOI: 10.1038/s41467-020-17440-w.
Comprehensive pharmacogenomic characterization of gastric cancer.
Sa J, Hong J, Lee I, Kim J, Sim M, Kim H
Genome Med. 2020; 12(1):17.
PMID: 32070411
PMC: 7029441.
DOI: 10.1186/s13073-020-0717-8.
Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6.
Gong M, Luo C, Meng H, Li S, Nie S, Jiang Y
Onco Targets Ther. 2019; 12:10011-10022.
PMID: 31819497
PMC: 6875503.
DOI: 10.2147/OTT.S227758.
Genomic characterization of early-stage esophageal squamous cell carcinoma in a Japanese population.
Urabe Y, Kagemoto K, Hayes C, Nakamura K, Masuda K, Ono A
Oncotarget. 2019; 10(41):4139-4148.
PMID: 31289612
PMC: 6609253.
DOI: 10.18632/oncotarget.27014.
Lineage tracing and targeting of IL17RB tuft cell-like human colorectal cancer stem cells.
Goto N, Fukuda A, Yamaga Y, Yoshikawa T, Maruno T, Maekawa H
Proc Natl Acad Sci U S A. 2019; 116(26):12996-13005.
PMID: 31182574
PMC: 6601016.
DOI: 10.1073/pnas.1900251116.
LINC01127 promotes the development of ovarian tumors by regulating the cell cycle.
Jing L, Gong M, Lu X, Jiang Y, Li H, Cheng W
Am J Transl Res. 2019; 11(1):406-417.
PMID: 30787997
PMC: 6357339.
C/EBPβ Is a Transcriptional Regulator of Wee1 at the G₂/M Phase of the Cell Cycle.
Lee J, Sung J, Choi E, Yoon H, Kang B, Hong E
Cells. 2019; 8(2).
PMID: 30754676
PMC: 6407104.
DOI: 10.3390/cells8020145.